Optometrist · Newark, NJ
NPI
1811059785
Since 2006
Specialty
Optometrist
Code 152W00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
875 Broad St
Newark, NJ, 07102
Phone (973) 622-4492
Groups this clinician bills Medicare through
Medicare paid, 2024
$19K
302 services
Medicare patients, 2024
127
Average age 71
Drug cost, 2024
$899K
1,249 prescriptions
Company payments, 2025
$2,337
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Diego X Morillo was code 92250 (angiography), 84 times for 82 patients. In total Diego X Morillo billed 302 services in 18 codes, and Medicare paid $19K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-04-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92250 Angiography | Office | 84 | 82 | $30.38 | $2,552 |
| 92012 Ophthalmological E&M | Office | 78 | 65 | $71.18 | $5,552 |
| 99213 Office E&M - Established | Office | 33 | 26 | $70.86 | $2,338 |
| 99204 Office E&M - New | Office | 19 | 19 | $126.71 | $2,407 |
| 92134 Computerized Ophthalmic Imaging | Office | 19 | 16 | $32.97 | $627 |
| 92133 Computerized Ophthalmic Imaging | Office | 18 | 16 | $30.78 | $554 |
| 99214 Office E&M - Established | Office | 15 | 15 | $93.56 | $1,403 |
| 99212 Office E&M - Established | Office | 13 | 12 | $38.57 | $501 |
By year: 2022 $21K for 326 services; 2023 $26K for 363 services; 2024 $19K for 302 services.
Medicare prescription drug claims, 2024
In 2024, the drug Diego X Morillo prescribed most often to Medicare patients was Xiidra (Lifitegrast), with 191 prescriptions and refills. In total Diego X Morillo wrote 1,249 Medicare prescriptions that cost $899K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Xiidra Lifitegrast | 191 | 371 | 82 | $255K |
| Cequa Cyclosporine | 185 | 345 | 79 | $198K |
| Latanoprost Generic | 138 | 223 | 43 | $1,040 |
| Restasis Cyclosporine | 115 | 157 | 58 | $96K |
| Miebo Perfluorohexyloctane/Pf | 91 | 141 | 53 | $83K |
| Lumigan Bimatoprost | 71 | 95 | 20 | $23K |
| Cyclosporine Generic | 71 | 286 | 42 | $85K |
| Vyzulta Latanoprostene Bunod | 44 | 64 | 19 | $19K |
| Prednisolone Acetate Generic | 42 | 46 | 31 | $1,443 |
| Vevye Cyclosporine | 40 | 67 | 23 | $35K |
| Tobramycin-Dexamethasone Tobramycin/Dexamethasone | 38 | 39 | 34 | $1,275 |
| Tyrvaya Varenicline Tartrate | 24 | 38 | 18 | $24K |
| Xdemvy Lotilaner | 22 | 34 | 22 | $42K |
| Fluorometholone Generic | 22 | 23 | 21 | $1,248 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 20 | 41 | Under 11 | $227 |
Brand drugs: 970 claims; generic drugs: 279 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Diego X Morillo $2,337 ($2,337 in general payments such as food, travel and fees) from 11 companies. The largest payer was Sun Pharmaceutical Industries Inc. with $625.
| Company | Payments | Amount |
|---|---|---|
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 19 | $625 |
| Tarsus Pharmaceuticals, Inc. TARS | 11 | $389 |
| Alcon Vision LLC ALC | 15 | $349 |
| Biotissue Holdings Inc. | 2 | $254 |
| Harrow Eye, LLC | 7 | $206 |
| Glaukos Corporation GKOS | 2 | $205 |
| RxSight Inc RXST | 1 | $147 |
| Dompe US, Inc. | 3 | $53.63 |
| Bausch & Lomb Americas Inc. BLCO | 3 | $48.13 |
| LENSAR, Inc. LNSR | 1 | $42.22 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.